Literature DB >> 22107606

Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken?

John Ayuk1.   

Abstract

Radiotherapy for pituitary adenomas is a well-established and effective treatment, but it has been linked to a number of complications, including an increased risk of cerebrovascular disease and mortality. Possible underlying mechanisms include the direct effects of radiation on cerebral vasculature and deficiencies in specific pituitary hormones. Higher administered dose of radiotherapy is one of the main predictors of stroke. Although treatment strategies for stroke prevention in patients treated with pituitary radiotherapy have not been studied, using the lowest effective radiation dose and ensuring hormone deficiencies are adequately treated may be beneficial in reducing the risk of stroke.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22107606     DOI: 10.1111/j.1365-2265.2011.04300.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Growth hormone in health and disease: Long-term GH therapy--benefits and unanswered questions.

Authors:  David Clemmons
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

2.  When Occam's razor fails: hemipontine infarct on a background of previous surgery and radiotherapy for craniopharyngioma.

Authors:  Ian S Boon; Dilani Perera; John Ayuk
Journal:  BMJ Case Rep       Date:  2016-04-07

Review 3.  Pituitary disease mortality: is it fiction?

Authors:  Eva Marie Erfurth; Peter Siesjö; Thomas Björk-Eriksson
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.